Renaissance Technologies - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 105 filers reported holding MEI PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2023$642
-1.1%
2,804,357
+5.3%
0.00%0.0%
Q4 2022$649
-99.9%
2,664,357
-1.9%
0.00%0.0%
Q3 2022$1,050,000
-36.3%
2,716,157
-0.4%
0.00%
-50.0%
Q2 2022$1,649,000
+187.3%
2,725,773
+186.1%
0.00%
+100.0%
Q1 2022$574,000
-75.2%
952,573
+9.9%
0.00%
-66.7%
Q4 2021$2,314,000
-16.1%
866,786
-13.2%
0.00%
-25.0%
Q3 2021$2,757,000
-16.6%
998,773
-13.9%
0.00%0.0%
Q2 2021$3,306,000
-46.1%
1,160,073
-35.2%
0.00%
-50.0%
Q1 2021$6,138,000
-8.9%
1,789,486
-29.9%
0.01%
+14.3%
Q4 2020$6,739,000
-30.9%
2,552,586
-18.3%
0.01%
-30.0%
Q3 2020$9,752,000
-28.7%
3,125,586
-5.6%
0.01%
-16.7%
Q2 2020$13,681,000
+177.5%
3,312,486
+8.2%
0.01%
+140.0%
Q1 2020$4,930,000
-33.4%
3,062,186
+2.6%
0.01%
-16.7%
Q4 2019$7,404,000
+55.0%
2,985,286
+5.0%
0.01%
+50.0%
Q3 2019$4,776,000
-25.5%
2,842,657
+10.8%
0.00%
-33.3%
Q2 2019$6,414,000
-1.7%
2,565,513
+20.7%
0.01%0.0%
Q1 2019$6,524,000
+6.3%
2,125,013
-8.6%
0.01%
-14.3%
Q4 2018$6,135,000
-36.4%
2,323,713
+3.9%
0.01%
-30.0%
Q3 2018$9,639,000
-23.8%
2,236,480
-45.6%
0.01%
+42.9%
Q2 2018$12,657,000
+223.3%
4,110,126
+117.3%
0.01%
+75.0%
Q1 2018$3,915,000
-7.4%
1,891,313
-6.1%
0.00%
-20.0%
Q4 2017$4,230,000
-19.6%
2,014,113
+2.5%
0.01%
-16.7%
Q3 2017$5,264,000
+35.0%
1,964,207
+20.4%
0.01%
+20.0%
Q2 2017$3,898,000
+53.8%
1,630,813
+4.2%
0.01%
+25.0%
Q1 2017$2,534,000
+78.5%
1,564,428
+58.6%
0.00%
+100.0%
Q4 2016$1,420,000
-31.3%
986,419
-16.1%
0.00%
-50.0%
Q3 2016$2,068,000
+144.7%
1,175,059
+89.1%
0.00%
+100.0%
Q2 2016$845,000
+40.1%
621,500
+29.8%
0.00%
+100.0%
Q1 2016$603,000
+37.0%
478,700
+73.9%
0.00%0.0%
Q4 2015$440,000
+2215.8%
275,300
+2213.4%
0.00%
Q3 2015$19,00011,9000.00%
Other shareholders
MEI PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
First Light Asset Management, LLC 8,637,475$23,839,0001.57%
Altium Capital Management LP 1,828,066$5,045,0001.32%
Opaleye Management Inc. 1,565,000$4,319,0000.81%
DAFNA Capital Management LLC 641,000$1,769,0000.47%
BVF INC/IL 3,532,057$9,748,0000.38%
Sio Capital Management, LLC 426,047$1,176,0000.38%
Boxer Capital, LLC 2,913,091$8,040,0000.28%
NEA Management Company, LLC 8,533,072$23,551,0000.28%
EMC Capital Management 95,372$269,0000.15%
Virtus ETF Advisers LLC 64,819$179,0000.08%
View complete list of MEI PHARMA INC shareholders